Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 3,338 Castle Biosciences, Inc. shares (Form 4)

Traded Jul 14, 2026 · Filed Jul 16, 2026

On Jul 14, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 3,338 Castle Biosciences, Inc. shares at US$22.92 for US$76,507 under a trading plan, leaving 12,090 shares. Filed Jul 16, 2026 (Form 4).

Sold
3,338 shares
Price
US$22.92
Value
US$76,507
Holding after
12,090 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 14, 2026Common StockOption exercise550US$2.3922,029Direct
Jul 14, 2026Common StockSale550US$22.9221,479Direct
Jul 14, 2026Common StockSale1,357US$22.9239,353Indirect
Jul 14, 2026Common StockSale1,153US$22.9233,449Indirect
Jul 14, 2026Common StockSale278US$22.9212,090Indirect

Source

View original at SEC

Related